277 related articles for article (PubMed ID: 21214510)
1. Focal adhesion kinase as a cancer therapy target.
Golubovskaya VM
Anticancer Agents Med Chem; 2010 Dec; 10(10):735-41. PubMed ID: 21214510
[TBL] [Abstract][Full Text] [Related]
2. Focal adhesion kinase and cancer.
Golubovskaya VM; Kweh FA; Cance WG
Histol Histopathol; 2009 Apr; 24(4):503-10. PubMed ID: 19224453
[TBL] [Abstract][Full Text] [Related]
3. Focal adhesion kinase: a potential target in cancer therapy.
van Nimwegen MJ; van de Water B
Biochem Pharmacol; 2007 Mar; 73(5):597-609. PubMed ID: 16997283
[TBL] [Abstract][Full Text] [Related]
4. Evolving therapies and FAK inhibitors for the treatment of cancer.
Dunn KB; Heffler M; Golubovskaya VM
Anticancer Agents Med Chem; 2010 Dec; 10(10):722-34. PubMed ID: 21291406
[TBL] [Abstract][Full Text] [Related]
5. Targeting focal adhesion kinase in neuroblastoma.
Gillory L; Beierle EA
Anticancer Agents Med Chem; 2010 Dec; 10(10):714-21. PubMed ID: 21269252
[TBL] [Abstract][Full Text] [Related]
6. Targeting focal adhesion kinase (FAK) for cancer therapy: FAK inhibitors, FAK-based dual-target inhibitors and PROTAC degraders.
Yang M; Xiang H; Luo G
Biochem Pharmacol; 2024 Jun; 224():116246. PubMed ID: 38685282
[TBL] [Abstract][Full Text] [Related]
7. Focal adhesion kinase and its signaling pathways in cell migration and angiogenesis.
Zhao X; Guan JL
Adv Drug Deliv Rev; 2011 Jul; 63(8):610-5. PubMed ID: 21118706
[TBL] [Abstract][Full Text] [Related]
8. The role of FAK in tumor metabolism and therapy.
Zhang J; Hochwald SN
Pharmacol Ther; 2014 May; 142(2):154-63. PubMed ID: 24333503
[TBL] [Abstract][Full Text] [Related]
9. Focal adhesion kinase inhibitors in the treatment of metastatic cancer: a patent review.
Shanthi E; Krishna MH; Arunesh GM; Venkateswara Reddy K; Sooriya Kumar J; Viswanadhan VN
Expert Opin Ther Pat; 2014 Oct; 24(10):1077-100. PubMed ID: 25113248
[TBL] [Abstract][Full Text] [Related]
10. Targeting focal adhesion kinase signaling in tumor growth and metastasis.
Schwock J; Dhani N; Hedley DW
Expert Opin Ther Targets; 2010 Jan; 14(1):77-94. PubMed ID: 20001212
[TBL] [Abstract][Full Text] [Related]
11. Oncogenic Receptor Tyrosine Kinases Directly Phosphorylate Focal Adhesion Kinase (FAK) as a Resistance Mechanism to FAK-Kinase Inhibitors.
Marlowe TA; Lenzo FL; Figel SA; Grapes AT; Cance WG
Mol Cancer Ther; 2016 Dec; 15(12):3028-3039. PubMed ID: 27638858
[TBL] [Abstract][Full Text] [Related]
12. Focal adhesion kinase-An emerging viable target in cancer and development of focal adhesion kinase inhibitors.
Chauhan A; Khan T
Chem Biol Drug Des; 2021 Mar; 97(3):774-794. PubMed ID: 33191630
[TBL] [Abstract][Full Text] [Related]
13. Focal adhesion kinase as potential target for cancer therapy (Review).
Hao H; Naomoto Y; Bao X; Watanabe N; Sakurama K; Noma K; Motoki T; Tomono Y; Fukazawa T; Shirakawa Y; Yamatsuji T; Matsuoka J; Wang ZG; Takaoka M
Oncol Rep; 2009 Nov; 22(5):973-9. PubMed ID: 19787209
[TBL] [Abstract][Full Text] [Related]
14. The roles of nuclear focal adhesion kinase (FAK) on Cancer: a focused review.
Zhou J; Yi Q; Tang L
J Exp Clin Cancer Res; 2019 Jun; 38(1):250. PubMed ID: 31186061
[TBL] [Abstract][Full Text] [Related]
15. FAK inhibitors in Cancer, a patent review.
Lv PC; Jiang AQ; Zhang WM; Zhu HL
Expert Opin Ther Pat; 2018 Feb; 28(2):139-145. PubMed ID: 29210300
[TBL] [Abstract][Full Text] [Related]
16. Targeting focal adhesion kinase in cancer-part I.
Golubovskaya VM
Anticancer Agents Med Chem; 2010 Dec; 10(10):713. PubMed ID: 21348852
[No Abstract] [Full Text] [Related]
17. Progress in the Development of Small Molecular Inhibitors of Focal Adhesion Kinase (FAK).
Lu Y; Sun H
J Med Chem; 2020 Dec; 63(23):14382-14403. PubMed ID: 33058670
[TBL] [Abstract][Full Text] [Related]
18. Drug Discovery Targeting Focal Adhesion Kinase (FAK) as a Promising Cancer Therapy.
Pang XJ; Liu XJ; Liu Y; Liu WB; Li YR; Yu GX; Tian XY; Zhang YB; Song J; Jin CY; Zhang SY
Molecules; 2021 Jul; 26(14):. PubMed ID: 34299525
[TBL] [Abstract][Full Text] [Related]
19. FAK signaling in human cancer as a target for therapeutics.
Lee BY; Timpson P; Horvath LG; Daly RJ
Pharmacol Ther; 2015 Feb; 146():132-49. PubMed ID: 25316657
[TBL] [Abstract][Full Text] [Related]
20. Understanding the roles of FAK in cancer: inhibitors, genetic models, and new insights.
Yoon H; Dehart JP; Murphy JM; Lim ST
J Histochem Cytochem; 2015 Feb; 63(2):114-28. PubMed ID: 25380750
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]